The Smoke and Mirrors of Vaping
How an alternative to cigarettes designed for health ended up making things worse.
2 min read · from UNINTENDED by Mayank Mehta
In 2003, a Chinese pharmacist named Hon Lik watched his father battle lung cancer. His father had been a heavy smoker. So had Hon Lik himself. Grief and guilt pushed him to invent something he believed could save millions of lives: a device that delivered nicotine without the tar, the carbon monoxide, or the thousands of toxic chemicals found in cigarette smoke.
The e-cigarette was born.
When the product reached Western markets, it was celebrated as a breakthrough. Public health advocates cautiously endorsed it. Smokers saw a lifeline. Doctors saw a way to wean their patients off a habit that was killing eight million people a year worldwide. The early data looked promising. If you could separate the nicotine from the combustion, maybe you could save the smoker without saving the cigarette.
Then the market did what markets do. It optimized.
Companies like JUUL redesigned the product for a generation that had never smoked. Sleek devices that looked like USB drives. Flavors like mango, mint, and creme brulee. Marketing that lived on Instagram and TikTok. The target audience shifted quietly from middle-aged smokers trying to quit to teenagers who had never held a cigarette in their lives.
It worked spectacularly. By the late 2010s, youth vaping rates had exploded. For millions of teenagers, the e-cigarette wasn't a path away from nicotine. It was the introduction to it. Studies began to show that young vapers were actually more likely to transition to traditional cigarettes, not less. Decades of progress in reducing youth tobacco use began to unravel.
Meanwhile, many adult smokers who had turned to vaping as a quitting tool simply added it to their routine. They smoked and vaped, doubling their exposure rather than eliminating it. Reports of respiratory damage, heart problems, and a mysterious lung disease called EVALI started surfacing in emergency rooms.
A tool designed to end addiction had instead expanded its audience. A product built as an exit ramp became an on-ramp. The inventor's grief had been real. The solution had been sincere. But once it entered the market, it stopped belonging to the man who made it and started belonging to the people who could profit from it most.